American Century Companies’s Impax Laboratories, Inc. IPXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-65,184
Closed -$1.05M 1436
2017
Q2
$1.05M Sell
65,184
-29,318
-31% -$433K ﹤0.01% 1133
2017
Q1
$1.2M Buy
+94,502
New +$1.14M ﹤0.01% 1115
2014
Q1
Sell
-120,623
Closed -$3.03M 1539
2013
Q4
$3.03M Sell
120,623
-142,215
-54% -$3.17M ﹤0.01% 1028
2013
Q3
$5.39M Hold
262,838
0.01% 870
2013
Q2
$5.24M Buy
+262,838
New +$4.67M 0.01% 835

Other funds holding IPXL

American Century Companies's IPXL Position: Q3 2017 in Review

American Century Companies sold out of Impax Laboratories, Inc. (IPXL) in Q3 2017, closing a stake of 65,184 shares — an estimated $1.05M sold.

American Century Companies first reported a position in IPXL in Q2 2013 and held it in 5 quarters. The position peaked at $5.39M in Q3 2013. 189 funds tracked by Wall St. Rank hold IPXL as of Q3 2017.

  • American Century Companies reported no remaining Impax Laboratories, Inc. position as of Q3 2017 after selling out during the quarter.
  • American Century Companies sold 65,184 Impax Laboratories, Inc. shares in Q3 2017, an estimated $1.05M.
  • American Century Companies first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 5 quarters.
  • American Century Companies's Impax Laboratories, Inc. position peaked at $5.39M in Q3 2013.
  • 189 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q3 2017.

Based on American Century Companies's 13F filing for Q3 2017, filed 1 Nov 2017.